Faro AI
Structured data and AI agents for clinical development and pharmaceutical trial operations.
$37.3MSeries B
LeadS
S32
Activity from announced rounds
Activity in this selectionUnited States · Aug 31, 2026 · Aug 1, 2026
S32, formerly identified as Section 32, is a venture firm whose stated focus includes AI, computational biology, physical AI, infrastructure, cybersecurity and enterprise technology.
Recorded funding activity
The RoundOS history includes Basecamp’s biological models, Snorkel’s training-data systems, Ema’s enterprise agents and Network Bio’s tissue-data models. These are covered financing announcements rather than a complete portfolio.
- Rounds participated in
- 2
- Confirmed lead rounds
- 1 1 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $87.3M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionNetwork Bio
Builds AI models trained on patient tissue and clinical data for disease diagnostics
$50MStrategic
Role not disclosed